TelePeptide review

What it is

TelePeptide (TelePeptide LLC, trade name TelePep) is a LegitScript-certified US direct-pay telehealth practice operated under MD Integrations, P.C., a contracted medical group. Its menu spans compounded GLP-1 weight care (injectable and dissolvable-tablet semaglutide and tirzepatide, a semaglutide-plus-naltrexone combination and microdose combos), a longevity line covering NAD⁺ as a shot, nasal spray or sublingual tablet and sermorelin as a subcutaneous shot or sublingual troche, plus hair restoration. It states 503A compounding pharmacies without naming them, and its LegitScript seal (ID 49966407) is preloaded in the page head and resolves on LegitScript's own host.

How it works

Asynchronous. You complete an intake, a licensed US physician reviews it — the practice states typically within 24 hours — and if a prescription is clinically appropriate, medication ships from a licensed compounding pharmacy. Its homepage adds 24/7 messaging with a care team, regular check-ins and dosage adjustments as included at every tier, which is the kind of ongoing contact an injectable prescription should carry. State coverage is published rather than claimed: 48 US states and the District of Columbia, with Alaska and Mississippi named as excluded. Naming the exclusions is a small thing that saves a reader from completing a health questionnaire only to be turned away, and most of this board does not do it. The disclosure gaps are consistent and worth stating together: no compounding pharmacy is named, no individual clinician or medical director is published, and the founder appears by first name only. So you can verify the certification and the medical group but not the people or the facility, which is a middling position — better than an anonymous storefront, short of a service that names its 503A partner outright.

Pricing transparency

The best-presented pricing in this batch, and the reason is presentational rather than numeric. Sermorelin is $159 a month with no commitment, $654 up front for six months ($109 a month) or $1,188 for a year ($99 a month). NAD⁺ is $169 a month with no commitment, $834 for six months ($139 a month) or $1,548 for a year ($129 a month). Because the month-to-month rate and the prepay totals appear on the same table, the low figure cannot pass itself off as a monthly price — a trap several competitors in our coverage fall into deliberately. Every price is stated to include the clinician evaluation, the prescription, the medication and shipping, with the practice's own line being "no insurance, no surprise fees". Two questions remain open and both are worth asking before you order. Neither dose nor vial size appears beside any figure, so you cannot tell what a month contains. And labs are not mentioned in any plan, which for sermorelin means no baseline IGF-1 is included even though that is the measurement most likely to tell a clinician whether the drug is doing anything.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Its own FAQ states the position clearly and without softening: compounded preparations are not FDA-approved drugs and are not generic versions of branded products. Medication is stated to come from 503A compounding pharmacies, which are not named, and compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, the two longevity products are not equal purchases. Sermorelin is a GHRH analogue that prompts your own pituitary to release growth hormone rather than supplying it, preserving a feedback loop that exogenous growth hormone overrides — a real, well-characterised mechanism whose long-term human outcome data thins out badly beyond short-term IGF-1 movement, and the sublingual troche route has less pharmacokinetic support than the injection. NAD⁺ is weaker still: the injected, intranasal and sublingual routes it sells have no controlled human outcome trials at all, while the forms with human trial data are the oral precursors NR and NMN, which raise a blood NAD⁺ level rather than demonstrate a clinical outcome. Individual results vary.

Pros and watch-outs

The evidence behind what TelePeptide prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• NAD injections: how to get them near you or online, and what the evidence really says

  Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.

• NAD⁺ nasal spray: the delivery format with the least direct evidence

  Intranasal NAD⁺ is convenient and heavily marketed — but no controlled human trial shows the spray raises systemic or brain NAD⁺. A straight comparison with the better-studied routes.

How TelePeptide compares

A few alternatives worth a look, depending on what you’re optimizing for.

• TWTyde Wellness

  NAD⁺ buyers who want five named pharmacies, a published state list and the route stated with the price

  See Tyde Wellness →
• THTrava Health

  Buyers who want six named pharmacies and will confirm the NAD⁺ figure against the product page, not the tile

  See Trava Health →
• TRTrueMe

  Buyers in its six states who want the NAD⁺ price visible before handing over any health history

  See TrueMe →